No Data
23andMe Inches Higher on Hookup With Mirador
Express News | 23Andme and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation
Express News | GSK PLC Reports 9.5% Stake in 23Andme Holding as of Nov 12 Vs Previous Stake of 11.2% as of Feb 7 - SEC Filing
23andMe Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After Reporting a Q2 Revenue Miss Yesterday.
23andMe Reports Improved Financial Metrics Amid Revenue Decline